BMY
40
2
JBHT
35
12
WU
34
14
ACN
36
5
WFC
72
4
AMZN
58
-2
O
39
2
EL
50
7
BK
61
3
CNP
49
-8
DVA
68
-2
NAVI
52
2
NWSA
58
-4
PSA
43
11
CVS
49
2
LEG
32
3
KO
47
3
CTAS
56
-3
KMX
47
9
EXR
33
-4
BMY
40
2
JBHT
35
12
WU
34
14
ACN
36
5
WFC
72
4
AMZN
58
-2
O
39
2
EL
50
7
BK
61
3
CNP
49
-8
DVA
68
-2
NAVI
52
2
NWSA
58
-4
PSA
43
11
CVS
49
2
LEG
32
3
KO
47
3
CTAS
56
-3
KMX
47
9
EXR
33
-4
Financhill
Back

Exelixis Quote, Financials, Valuation and Earnings

BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty

Click here now to prepare yourself for what's around the corner
Buy
54

EXEL
Exelixis

Last Price:
22.32
Seasonality Move:
4%

7 Day Trial

ALL ACCESS PASS

$ 7

Election Shock on August 19th?

Click here now to see the evidence I've gathered.

Exelixis Price Quote

$22.32
-0.17 (-0.76%)
(Updated: April 19, 2024 at 12:10 PM ET)

Exelixis Key Stats

Buy
54
Exelixis (EXEL) is a Buy
Day range:
$22.46 - $23.23
52-week range:
$18.08 - $24.34
Dividend yield:
0%
P/E ratio:
34.60
P/S ratio:
3.95
P/B ratio:
3.01%
Volume:
2.6M
Avg. volume:
2.2M
1-year change:
17.5%
Market cap:
$6.8B
Revenue:
$1.8B
EPS:
$0.64

How Much Does Exelixis Make?

  • How Much Are Exelixis's Sales Annually?
    EXEL Revenues are $1.8B
  • How Much Profit Does Exelixis's Make A Year?
    EXEL net income is $207.8M

Is Exelixis Growing As A Company?

  • What Is Exelixis's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.13%
  • What Is Exelixis's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Exelixis Stock Price Performance

  • Did Exelixis Stock Go Up Last Month?
    Exelixis share price went down by -2.93% last month
  • Did EXEL's Share Price Rise Over The Last Year?
    EXEL share price rose by 17.5% over the past 1 year

What Is Exelixis 52-Week High & Low?

  • What Is Exelixis’s 52-Week High Share Price?
    Exelixis has traded as high as $24.34 over the past 52 weeks
  • What Is Exelixis’s 52-Week Low Share Price?
    Exelixis has traded as low as $18.08 over the past 52 weeks

Exelixis Price To Free Cash Flow

  • Is Exelixis Stock Overvalued?
    Exelixis is trading at a price to free cash flow ratio of 42.44
  • Is Exelixis Stock Undervalued?
    Exelixis EV to Free Cash Flow ratio is 34.18
  • What Is Exelixis’s Price Earnings Growth Ratio?
    EXEL PEG ratio is 2.72
  • Is Exelixis Trading At A Premium To Earnings?
    Exelixis EV to EBIT ratio is 34.08

Is It Risky To Buy Exelixis?

  • How Much Debt Does Exelixis Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Exelixis Have?
    Cash and short term investments quarterly total is $995.3M
  • What Is Exelixis’s Book Value Per Share?
    Book value per share is 7.48

Is Exelixis Cash Flow Positive?

  • What Is EXEL Cash Flow From Operations?
    Cash flow from operations (TTM) is $333.3M
  • What Is Exelixis’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$546.1M
  • What Is Exelixis’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$27M

Exelixis Return On Invested Capital

  • Is Management Doing A Good Job?
    EXEL return on invested capital is 8.53%
  • What Is Exelixis Return On Assets?
    ROA measures how assets are converting to revenues and is 6.8%
  • What Is EXEL Return On Equity?
    ROE is a measure of profitability and is 8.53%

Exelixis Earnings Date & Stock Price

  • What Is Exelixis's Stock Price Today?
    A single share of EXEL can be purchased today for 22.49
  • What Is Exelixis’s Stock Symbol?
    Exelixis trades on the nasdaq under the ticker symbol: EXEL
  • When Is Exelixis’s Next Earnings Date?
    The next quarterly earnings date for Exelixis is scheduled on April 30, 2024
  • When Is EXEL's next ex-dividend date?
    Exelixis's next ex-dividend date is April 19, 2024
  • How To Buy Exelixis Stock?
    You can buy Exelixis shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Exelixis Competitors

  • Who Are Exelixis's Competitors?
    Below is a list of companies who compete with Exelixis or are related in some way:
    • Bristol-Myers Squibb Co (BMY)
    • Incyte Corp (INCY)
    • Legend Biotech Corp (LEGN)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Bio-Techne Corp (TECH)

Exelixis Dividend Yield

Data Unavailable

Exelixis Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.8%
Revenue: 13.15% 0.36%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 26.63
Upside from Last Price: 18.43%

Major Shareholders

  • How many EXEL shares are owned by institutional investors?
    378.4M EXEL shares are owned by institutional investors
  • How many EXEL shares are owned by insiders?
    8.9M EXEL shares are owned by insiders